NHS National Framework for Golimumab Injection
Estimated value
—
Awarded value
£60.0m
Suppliers
3
Lots
1
Published
01 Sept 2025
Description
NHS National Framework for Golimumab Injection commencing 1st November 2025 Offer reference number: CM/TNS/25/5724 Period of framework: 1 November 2025 to 31 October 2026 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 48 months. Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
Scope
- Reference
- C366698
- Commercial tool
- Standalone contract
- Contract dates
- 01 Nov 2025 to 31 Oct 2026Possible extension to 31 Oct 2029
Option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 48 months.
- CPV classifications
- 33600000
- Contract locations
- North East England, United KingdomNorth West England, United KingdomEast Midlands, United KingdomWest Midlands, United KingdomEast of England, United KingdomSouth East England, United KingdomSouth West England, United Kingdom
- Particular suitability
- Small and medium-sized enterprises (SME)
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Price is not the only award criterion | — | price | 100.00% |
Submission & procedure
- Procedure
- Open procedure
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£60.0m
Award date
25 Aug 2025
Contract start
01 Nov 2025
Contract end
31 Oct 2026